| 13/03/23 | 07:30:04 | 13 Mar 2023 | | Confirmation of No Exposure to Silicon Valley Bank | RNS |
| 08/03/23 | 07:00:06 | 8 Mar 2023 | | Creation of New Novel Family of mRNA Therapeutics | RNS |
| 06/03/23 | 07:00:02 | 6 Mar 2023 | | Formation of Scientific Advisory Board | RNS |
| 01/03/23 | 07:00:12 | 1 Mar 2023 | | Company Presentation | RNS |
| 27/02/23 | 15:30:02 | 27 Feb 2023 | | Holding(s) in Company | RNS |
| 24/02/23 | 14:05:48 | 24 Feb 2023 | | Second Price Monitoring Extn | RNS |
| 24/02/23 | 14:00:30 | 24 Feb 2023 | | Price Monitoring Extension | RNS |
| 21/02/23 | 07:00:08 | 21 Feb 2023 | | Investor Presentation | RNS |
| 20/02/23 | 07:00:03 | 20 Feb 2023 | | Randox Licence and Royalty Agreement | RNS |
| 17/02/23 | 14:05:38 | 17 Feb 2023 | | Second Price Monitoring Extn | RNS |
| 17/02/23 | 14:00:10 | 17 Feb 2023 | | Price Monitoring Extension | RNS |
| 15/02/23 | 15:00:01 | 15 Feb 2023 | | Holding(s) in Company | RNS |
| 07/02/23 | 07:00:03 | 7 Feb 2023 | | Operations Update | RNS |
| 30/01/23 | 16:00:01 | 30 Jan 2023 | | Grant of Share Options | RNS |
| 27/01/23 | 16:15:01 | 27 Jan 2023 | | Holding(s) in Company | RNS |
| 25/01/23 | 15:00:01 | 25 Jan 2023 | | Holding(s) in Company | RNS |
| 24/01/23 | 07:00:03 | 24 Jan 2023 | | MDK Oncology Antibodies Demonstrate In-Vivo Safety | RNS |
| 20/01/23 | 12:40:01 | 20 Jan 2023 | | Holding(s) in Company | RNS |
| 20/01/23 | 12:40:01 | 20 Jan 2023 | | Total Voting Rights | RNS |
| 18/01/23 | 08:36:18 | 18 Jan 2023 | | Holding(s) in Company | RNS |
| 17/01/23 | 11:05:38 | 17 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 17/01/23 | 11:00:35 | 17 Jan 2023 | | Price Monitoring Extension | RNS |
| 17/01/23 | 09:05:31 | 17 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 17/01/23 | 09:00:21 | 17 Jan 2023 | | Price Monitoring Extension | RNS |
| 17/01/23 | 07:00:06 | 17 Jan 2023 | | Placing and Appointment of Joint Broker | RNS |
| 16/01/23 | 07:00:06 | 16 Jan 2023 | | Appointment of Auditor | RNS |
| 09/01/23 | 07:00:01 | 9 Jan 2023 | | Operations Update | RNS |
| 05/01/23 | 07:00:05 | 5 Jan 2023 | | Operations Update | RNS |
| 13/12/22 | 13:30:01 | 13 Dec 2022 | | Director/PDMR Shareholding | RNS |
| 08/12/22 | 15:21:03 | 8 Dec 2022 | | Director/PDMR Shareholding | RNS |
| 05/12/22 | 08:07:52 | 5 Dec 2022 | | Presentation of Midkine Oligonucleotide Program | RNS |
| 01/12/22 | 14:00:06 | 1 Dec 2022 | | Resignation of Auditor | RNS |
| 09/11/22 | 07:00:04 | 9 Nov 2022 | | Mineral Resource Estimate | RNS |
| 31/10/22 | 11:06:02 | 31 Oct 2022 | | Second Price Monitoring Extn | RNS |
| 31/10/22 | 11:00:48 | 31 Oct 2022 | | Price Monitoring Extension | RNS |
| 25/10/22 | 16:42:00 | 25 Oct 2022 | | Second Price Monitoring Extn | RNS |
| 25/10/22 | 16:36:55 | 25 Oct 2022 | | Price Monitoring Extension | RNS |
| 25/10/22 | 07:00:06 | 25 Oct 2022 | | Midkine Antibody Program - Festival of Biologics | RNS |
| 11/10/22 | 07:00:17 | 11 Oct 2022 | | ROQ Presents Study Results at the ESGCT Conference | RNS |
| 06/10/22 | 07:00:08 | 6 Oct 2022 | | Director/PDMR Shareholding | RNS |
| 30/09/22 | 07:01:03 | 30 Sept 2022 | | Half-year Report | RNS |
| 30/09/22 | 07:00:15 | 30 Sept 2022 | | Precious Metals Production Project | RNS |
| 28/09/22 | 07:00:12 | 28 Sept 2022 | | Director/PDMR Shareholding | RNS |
| 26/09/22 | 14:30:08 | 26 Sept 2022 | | Director/PDMR Shareholding | RNS |
| 23/09/22 | 07:00:06 | 23 Sept 2022 | | Interim Results to 30 June 2022 | RNS |
| 22/09/22 | 07:00:09 | 22 Sept 2022 | | OMCO Drilling Results | RNS |
| 16/09/22 | 08:00:04 | 16 Sept 2022 | | Investor Presentation | RNS |
| 16/09/22 | 07:01:01 | 16 Sept 2022 | | Board and Management Appointments | RNS |
| 16/09/22 | 07:00:04 | 16 Sept 2022 | | Acquisition Completion, Admission & Voting Rights | RNS |
| 15/09/22 | 12:26:17 | 15 Sept 2022 | | Notice of Admission | RNS |
